Time is ticking away with the next submission deadline for #SBIR and #STTR applications being Jan. 5, 2025. We will offer three Q&A sessions with program officers from NINDS Small Business Programs for Jan. 5 SBIR/STTR Applicants. Anyone is welcome to join these meetings to ask non-confidential questions related to the submission process. Friday, Dec. 13 1:00 – 2:00 pm ET: https://lnkd.in/eS28nVZW Friday, Dec. 20 3:00 – 4:00 pm ET: https://lnkd.in/e_tu5KhE Thursday, Jan. 2 4:00 – 5:00 pm ET: https://lnkd.in/eanGDg28
NINDS Small Business Programs
政府管理
Rockville，MD 402 位关注者
Committed to helping small businesses commercialize technologies that are significant, innovative, and relevant to NINDS
关于我们
National Institutes of Health (NIH) small business program is a congressionally-mandated set-aside program to encourage research and development leading to commercialization. The program, as established by law, is intended to stimulate a partnership of ideas and technologies in the private sector and strengthen the role of small business in meeting Federal research or research and development (R/R&D) needs. The small business program at NINDS is used to achieve the mission of the Institute by supporting innovative ideas at different stages of development, including applied bench research, translational research, and early-stage clinical trials. While NINDS has specific funding opportunities, many of our applications are investigator-initiated and come in through the general NIH SBIR and STTR omnibus solicitations. Please contact program staff if you have questions about which institute(s) would be the best fit for your project. The NINDS small business program has two main component programs Small Business Innovation Research (SBIR) Program - A set-aside program, currently 3.2% of the NINDS budget, for small business concerns to engage in federal R/R&D with the potential for commercialization. Small Business Technology Transfer (STTR) Program - A set-aside program, currently 0.45% of the NINDS budget, to facilitate cooperative R/R&D with the potential for commercialization between small business concerns and U.S. research institutions. The applicant success rates of both the SBIR and STTR programs depend on the budget and the number of applications and can fluctuate from year to year. While the STTR budget is significantly smaller, historically the program gets far fewer applications. Applicants are encouraged to read about both programs and pick the one that best fits their project.
- 网站
-
https://www.ninds.nih.gov/funding/small-business-grants
NINDS Small Business Programs的外部链接
- 所属行业
- 政府管理
- 规模
- 11-50 人
- 总部
- Rockville，MD
动态
-
Did you know we offer a monthly office hour on the 2nd Wednesday of every month for all your SBIR/STTR questions? Our next one is Dec. 11. The focus will be "Beyond Omnibus Funding" but you are welcome to join and ask general questions. To join use this LINK: https://lnkd.in/gnV7XjyG
-
-
NINDS Small Business Programs转发了
Planning to submit for the National Institute on Aging (NIA) Start-Up Challenge and Accelerator but missed the pre-submission webinar and Q&A session? We’ve got you covered. Check out our website to view the pre-submission webinar and learn how the Challenge and Accelerator can advance your healthy aging solution toward commercialization: go.nih.gov/UZfAJRM Still have questions? ?? Email [email protected]. #NIAStartUpChallenge #AgingResearch
-
Peer Learning and Networking (PLAN) Webinar Series: CEO Perspectives on Launching & Growing #Biotech Start-Ups Join NCI SBIR Development Center on Tuesday, November 19, 2024, from 2:00-3:30 p.m. ET for a #SBIR Peer Learning and Networking (PLAN) webinar where Lu Alleruzzo, Co-founder and CEO of Immunophotonics, Inc.; William Bozza, Program Director for NCI SBIR Development Center and Brittany Connors, Director of Investor Relations, NCI SBIR Development Center will be presenting. #entrepreneurship #startups https://lnkd.in/e-KEP7Ac
-
The Small Business Innovation Research (#SBIR) and Small Business Technology Transfer (#STTR) programs offer small business #entrepreneurs in #lifesciences #nondilutivefunding to support research and development.???? There is an upcoming webinar on Wednesday, November 13, at 1:00 p.m. ET Where you can?learn more about open funding opportunities, common application errors, and how to avoid them.?Registration link is below if interested in attending.
-
Are you a National Institute of Neurological Disorders and Stroke (NINDS) #smallbusiness awardee? Do you plan on applying for #SBIR/#STTR funding? Want to learn about exciting trans-NIH as well as institute/center specific programs? If so, subscribe to the NIH SEED newsletter! https://lnkd.in/dCmb9vrC
National Institutes of Health Office of Extramural Research - Stay updated on events, initiatives and funding opportunities!
public.govdelivery.com
-
It’s a beautiful day to be in Chicago for the #chicagobioinvestorsummit put together by Chicago Biomedical Consortium. The NINDS Small Business Programs has a table, if you are at the event stop by to chat about the #SBIR and #STTR small business program and some of our phenomenal companies.
-
-
The NIH #Blueprint Neurotherapeutics Network (#BPN) for Small Molecules is hosting a Q&A Webinar on Wednesday, November 6 at 3:00 PM EST. BPN for #SmallMolecules provides #nondilutive support for #drugdiscovery and development, from hit-to-lead chemistry through phase I clinical testing. Program Director Charles Cywin will provide an overview of the program and answer questions about the application process. Investigators interested in learning about the BPN-Small Molecule program are encouraged to register in advance for this webinar: https://lnkd.in/eW6texGf #SBIR #STTR #entrepreneur
-
NINDS Small Business Programs转发了
The NCI #SBIR #STTR Training and Entrepreneurship Program (STEP) is now accepting applications! Learn how you can get support with entrepreneurship and SBIR/STTR application prep during the October 8 webinar:?https://lnkd.in/eHMB8c6q
-
-
If you are working on a biologic therapy for a #neurodegenerative disease or #stroke, consider registering for the upcoming #Blueprint #Neurotherapeutics for biologics (BPN-Biologics) Q&A webinar on Oct. 23 at 2pm ET. This would include biotechnology products and biologics-based therapies such as peptides, proteins, and antibodies, gene-based therapies such as oligonucleotide and viral based cell therapies, as well as other novel emerging therapies including microbial and microbiome therapies. #BPNBiologics?provides #nondilutive funding and resources for drug discovery and development, from lead optimization through phase I clinical testing. Investigators interested in learning about the program can register here: https://lnkd.in/ezN-_r-U